Enhancement of uptake with estradiol treatment of a radiolabeled irreversible competitive enzyme inhibitor in the adrenal cortices and ovaries of rats with endocrine "autonomous" breast carcinomas.
D000311:Adrenal Glands / Q000378:metabolism*; D000818:Animals; D002250:Carbon Radioisotopes; D004958:Estradiol / Q000494:pharmacology*; D005260:Female; D006913:Hydroxysteroid Dehydrogenases / Q000037:antagonists & inhibitors; D007535:Isomerases / Q000037:antagonists & inhibitors; D007664:Ketosteroids; D008325:Mammary Neoplasms, Experimental / Q000378:metabolism*; D009368:Neoplasm Transplantation; D010053:Ovary / Q000378:metabolism*; D010080:Oxazoles / Q000378:metabolism*; D051381:Rats; D013739:Testosterone / Q000494:pharmacology
D002250:Carbon Radioisotopes; D007664:Ketosteroids; D010080:Oxazoles; D013739:Testosterone; D004958:Estradiol; D006913:Hydroxysteroid Dehydrogenases; D007535:Isomerases